TY  - GEN
AU  - Richardson,Paul G
AU  - Blood,Emily
AU  - Mitsiades,Constantine S
AU  - Jagannath,Sundar
AU  - Zeldenrust,Steven R
AU  - Alsina,Melissa
AU  - Schlossman,Robert L
AU  - Rajkumar,S Vincent
AU  - Desikan,K Raman
AU  - Hideshima,Teru
AU  - Munshi,Nikhil C
AU  - Kelly-Colson,Kathleen
AU  - Doss,Deborah
AU  - McKenney,Mary L
AU  - Gorelik,Svetlana
AU  - Warren,Diane
AU  - Freeman,Andrea
AU  - Rich,Rebecca
AU  - Wu,Anfang
AU  - Olesnyckyj,Marta
AU  - Wride,Kenton
AU  - Dalton,William S
AU  - Zeldis,Jerome
AU  - Knight,Robert
AU  - Weller,Edie
AU  - Anderson,Kenneth C
TI  - A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma
SN  - 0006-4971
PY  - 2007///0109
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Dexamethasone
KW  - Female
KW  - Humans
KW  - Lenalidomide
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - complications
KW  - Peripheral Nervous System Diseases
KW  - chemically induced
KW  - Recurrence
KW  - Remission Induction
KW  - methods
KW  - Salvage Therapy
KW  - adverse effects
KW  - Survival Analysis
KW  - Survival Rate
KW  - Thalidomide
KW  - Venous Thrombosis
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2006-04-015909
ER  -